Lysando
Pre-clinicalLysando® develops microbiome-friendly technologies to reduce bacterial threats and support the body’s natural balance through safe, targeted protein innovations.
Founded
2015
Focus
Biologics
About
Lysando® develops microbiome-friendly technologies to reduce bacterial threats and support the body’s natural balance through safe, targeted protein innovations.
Funding History
2Total raised: $2M
Grant$500KFinnish Funding Agency for InnovationJun 15, 2020
Seed$1.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationHelsinki, Finland
StagePre-clinical
Contact
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile